Home » Topics » BioWorld Science

BioWorld Science
RSS

Use of metabotropic glutamate receptor potentiators discussed by Lilly

Sep. 19, 2001

Inhibitors of uPA binding and use as antitumor agents discussed by Roche

Sep. 19, 2001

Abbott presents new research findings in the area of protein farnesyltransferase inhibitors

Sep. 19, 2001

New chemical series from American Cyanamid inhibits TACE and MMPs

Sep. 19, 2001

Elastase inhibitors such as elafin may have clinical utility in intimal hyperplasia

Sep. 19, 2001

Novel class of small nonpeptidyl compounds selectively inhibit malarial plasmepsins

Sep. 19, 2001

Levodopa with physiotherapy may improve motor recovery in stroke

Sep. 19, 2001

XTL continues to build strong infectious disease therapeutic pipeline

Sep. 19, 2001

M-40403 improves diabetic vascular dysfunction and nerve damage

Sep. 19, 2001

Orion drops development of gel formulation of progestin

Sep. 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...